Amy Hooper Kearbey advises clients on health care fraud and abuse laws and digital health strategy. She represents a broad range of health industry stakeholders, including hospital systems, medical societies, pharmaceutical and medical device companies, clinical laboratories, and data informatics companies.
Amy assists clients in the development of compliance policies and programs, Office of Inspector General (OIG) audits and investigations, securing OIG Advisory Opinions, and defense of False Claims Act cases based on alleged violations of the Stark Law and the Anti-Kickback Statute.
Amy also has extensive experience advising clients on digital health and data privacy matters, with an emphasis on the complex issues associated with “Big Data” initiatives. She works with clients on strategic approaches to the development and implementation of these initiatives and provides counsel on the nuanced and evolving requirements under federal and state privacy laws, including the Health Insurance Portability and Accountability Act (HIPAA). She has particular experience developing data repositories and data initiatives that are oriented around principles of rapid learning for health care, quality improvement, and clinical decision support.
While in law school, Amy served as president of the Health Law Society and was executive editor of the Duke Law & Technology Review. Prior to law school, she worked for a health care consulting firm, where she focused on strategic business planning issues for hospitals.